Loading data
BNRNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 77.16 m USD | 70.67 m USD | 75.7 m USD | 81.66 m USD |
| Cost of revenue | 19.54 m USD | 21.02 m USD | 24.54 m USD | 26.56 m USD |
| Gross profit | 57.62 m USD | 49.65 m USD | 51.16 m USD | 55.1 m USD |
| Research and development expense | 23.81 m USD | 31.82 m USD | 48.88 m USD | 61.17 m USD |
| Operating profit | -7.84 m USD | -48.99 m USD | -94.27 m USD | -142.15 m USD |
| Income tax expense | 223 k USD | 806 k USD | 336 k USD | 288 k USD |
| Net income (reported basis) | -7.92 m USD | -47.49 m USD | -92.07 m USD | -140.82 m USD |
| Net income attributable to common shareholders | — | — | — | -140.82 m USD |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.